Salem Investment Counselors Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Salem Investment Counselors Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$0.28 - $1.16 $542,724 - $2.25 Million	-1,938,300 Reduced 40.73%	2,820,285 $930,000
Q1 2024 Apr 11, 2024	BUY	$1.06 - $1.67 $2.65 Million - $4.17 Million	2,499,425 Added 110.64%	4,758,585 $5.52 Million
Q4 2023 Jan 16, 2024	BUY	$1.26 - $1.79 $341,226 - $484,758	270,815 Added 13.62%	2,259,160 $3.82 Million
Q3 2023 Oct 04, 2023	BUY	$1.61 - $2.54 $647,453 - $1.02 Million	402,145 Added 25.35%	1,988,345 $3.6 Million
Q2 2023 Jul 19, 2023	BUY	$1.14 - $1.95 $193,001 - $330,135	169,300 Added 11.95%	1,586,200 $2.95 Million
Q1 2023 May 11, 2023	BUY	$1.2 - $2.19 $530,574 - $968,297	442,145 Added 45.36%	1,416,900 $1.88 Million
Q4 2022 Feb 15, 2023	BUY	$1.63 - $3.52 $26,569 - $57,376	16,300 Added 1.7%	974,755 $1.65 Million
Q3 2022 Nov 09, 2022	BUY	$0.73 - $3.74 $627,340 - $3.21 Million	859,371 Added 867.32%	958,455 $2.99 Million
Q2 2022 Aug 17, 2022	BUY	$2.2 - $4.2 $217,984 - $416,152	99,084 New	99,084 $236,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Salem Investment Counselors Inc with notifications on news.